Part I: Liver function in oncology: biochemistry and beyond
Authors:
- Chris DowCDChris Dow
- Michael MichaelMMMichael Michael
- 1 November 2008
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 9 (11) , 1092-1101
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATIONMolecular Interventions, 2007
- Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastasesBritish Journal of Surgery, 2007
- Imatinib Mesylate (Gleevec) HepatotoxicityDigestive Diseases and Sciences, 2007
- Adenosine A2Areceptors play a role in the pathogenesis of hepatic cirrhosisBritish Journal of Pharmacology, 2006
- Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patientsBreast Cancer Research and Treatment, 2004
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Hepatotoxicity of ChemotherapyThe Oncologist, 2001
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatmentsJournal of Hepatology, 1991